RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 
| Contact | Wendy Slatery | FOR IMMEDIATE RELEASE |
| Telephone | 913-742-4456 | Sept. 26, 2016 |
| [email protected] | ||
Olathe, Kan., Sept. 26, 2016 -- The NTrainer System by Innara Health has been named an Innovative Technology by Vizient, Inc., and will be exhibited at the Vizient Innovative Technology Exchange Sept. 29 in Dallas. The NTrainer System is an FDA-cleared solution that assesses and develops non-nutritive suck (NNS) in infants and newborns born prematurely.
The expo attracts more than 2,000 clinicians from across the United States to learn about new technologies that improve clinical outcomes, enhance safety or drive improvements to the health care business model.
“It’s an honor for the NTrainer to be named an Innovative Technology and an exciting opportunity to bring unique solutions to the Vizient membership,” said Michael Peck, president and CEO of Innara Health. “We are eager to show the clinicians in attendance how the NTrainer System can help them shorten length of stay (LOS) for premature infants in the NICU, improving clinical efficiency and patient outcomes at their hospitals.”
At the event, Innara will have the opportunity to demonstrate its solution for clinicians and hospital executives, and present clinical evidence in support of its technology, including the recently released study that showed use of the NTrainer System to provide patterned oral stimulation resulted in significant reduction in LOS in preterm infants.
Vizient is the largest member-owned health care company in the country with a diverse membership and customer base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers.
# # #
About Innara Health
Innara Health’s mission is to advance the global understanding and improvement of neonatal, pediatric and adult feeding. The company offers the FDA-cleared NTrainer System, the first neonatal technology that assesses and develops non-nutritive suck (NNS) for newborns and infants born prematurely. Neonatal clinicians use the NTrainer System in children’s hospitals, medical centers and rehabilitation hospitals. For more information, visit innarahealth.com.
